Russia’s first potential Covid-19 vaccine will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards, a development source close to the matter told Reuters.
If you are not happy with the results below please do another search
50 search results for:
Roche’s attempt to retool the company’s rheumatoid arthritis drug Actemra/RoActemra to treat patients hospitalized with severe Covid-19-related pneumonia failed in a late-stage trial.
A study published in the journal Cell Stem Cell revealed how aging can cause lung regeneration to go awry, which can potentially lead to lung cancer and other diseases.
Moderna Inc. is planning to price the company’s coronavirus vaccine at $50 to $60 per course — higher than other vaccine makers have agreed to charge governments, the Financial Times reported.
The U.S. House of Representatives approved a $3.2 billion budget proposal for the U.S. Food and Drug Administration that will boost the regulatory agency’s abilities to approve new medicines and medical devices, as well as protect the nation’s food supplies.
Cambridge, Massachusetts-based Praxis Precision Medicines raised about $110 million in a Series C financing, led by Eventide Asset Management,
AstraZeneca reported successful results from the company’s Phase III DAPA-CKD clinical trial of Farxiga (dapagliflozin) in end-stage kidney disease.
Scientists succeeded in reviving microbes retrieved from sediment deep under the seafloor in the heart of the South Pacific that had survived in a dormant state for 101.5 million years in research illustrating the resiliency of life on Earth.
This panel discussion will feature the top minds in infectious diseases, virology and vaccinology, who will give participants a breakdown of the top vaccine candidates and the latest information on clinical trials.
W2O, a leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, announced the acquisition of Discern Health.